XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Sales:    
Net sales $ 42,292 $ 36,568
Costs and expenses:    
Research and development 4,567 4,287
Sales, marketing and support 7,546 8,700
General and administrative 7,143 6,398
Total costs and expenses 45,899 44,216
Loss from operations (3,607) (7,648)
Interest income 233 313
Interest expense 18 4
Other (expense) income, net (789) 1,502
Loss before income tax (benefit) expense (4,181) (5,837)
Income tax (benefit) expense (153) 377
Net loss $ (4,028) $ (6,214)
Net loss per common share    
Basic and diluted (in USD per share) $ (0.22) $ (0.35)
Weighted average number of common shares outstanding:    
Basic and diluted (in shares) 17,938,000 17,529,000
Product    
Sales:    
Net sales $ 18,432 $ 13,094
Costs and expenses:    
Costs of sales 11,220 9,636
Service    
Sales:    
Net sales 23,860 23,474
Costs and expenses:    
Costs of sales $ 15,423 $ 15,195